While both the United States and Europe strive to provide excellent cancer care, their systems differ significantly. The US often emphasizes cutting-edge treatments, sometimes leading to higher costs. In contrast, European systems tend to prioritize proactive care and cost-effectiveness, emphasizing early screening. This can result in distinct pati